Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin type A for chronic orofacial pain in myofascial temporomandibular disorder
RBR-8fsspyyCompleted
- Sponsor
- Universidade de São Paulo
- Start
- Oct 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial of botulinum toxin type A in temporomandibular disorder (TMD) and Craniofacial pain (2 arms), sponsored by Universidade de São Paulo. Primary endpoint: Not reported. Started Oct 2019; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
temporomandibular disorder (TMD)Craniofacial pain
Beyond the preview
Go deeper on RBR-8fsspyy.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-8fsspyy.